Johnson & Johnson Covid-19 Vaccine Pause Disrupts Appointments in New York Region
By Kate King
Thousands of Covid-19 vaccination appointments had to be
rescheduled across the tri-state region Tuesday after governors
said they would pause giving Johnson & Johnson's vaccine while
U.S. health officials investigate rare but serious blood clots.
Health officials from New York, New Jersey and Connecticut said
they would work to reschedule all pending Johnson & Johnson
vaccine appointments as quickly as possible with doses from Pfizer
Inc. and Moderna Inc. Nationwide, six women who received the
Johnson & Johnson vaccine developed blood clots out of more
than 6.8 million doses administered, the U.S. Food and Drug
Administration and the U.S. Centers for Disease Control and
Prevention said Tuesday.
About 4,000 Johnson & Johnson vaccination appointments will
be rescheduled in New York City Tuesday, Mayor Bill de Blasio said
at a news conference. The pause also means the city's program for
vaccinating homebound residents, which uses the single-dose Johnson
& Johnson shot, will be suspended, he said.
Mr. de Blasio, who himself received the Johnson & Johnson
vaccine last month, said more than 230,000 of the company's vaccine
doses had been administered without blood clots. He credited the
vaccine with helping battle coronavirus in the city, where hospital
admissions and the case positivity rate are falling. In total,
nearly 5.2 million doses have been administered citywide.
"We're starting to make some real progress, and Johnson &
Johnson has been a part of that," the mayor said. "We believe in
the effectiveness of this vaccine, but obviously we take seriously
any warning and it has to be seriously investigated."
The State University of New York's chancellor told students set
to receive Johnson & Johnson vaccines that they would need to
reschedule their appointments. The disruption came one day after
Gov. Andrew Cuomo announced an initial allocation of 21,000
vaccines for SUNY students, all Johnson & Johnson doses, as
well as 14,000 vaccines for private colleges in the state.
Mr. Cuomo's office didn't respond to questions Tuesday about how
many Johnson & Johnson vaccinations have been given statewide
and how many would need to be rescheduled because of the pause. In
total, more than 12 million vaccine doses of all brands have been
administered since December and nearly a quarter of the state's
population is fully vaccinated, his office said Monday.
More than 100,000 Connecticut residents have received Johnson
& Johnson vaccines without serious complications, the state
Department of Health said Tuesday. Gov. Ned Lamont said the pause
could affect 21,000 Johnson & Johnson doses anticipated for
this week, but he doesn't expect it to significantly delay the
state's overall vaccination efforts.
Connecticut expects to receive a 7% to 8% increase in Pfizer and
Moderna vaccine deliveries next week from the federal government,
and appointments are currently available for scheduling, according
to the governor. Mr. Lamont said he was worried that pausing
Johnson & Johnson vaccinations could exacerbate vaccine
hesitancy among residents.
"I'm less concerned about supply and becoming more concerned
about demand," he said. "It's a million times safer getting
vaccinated than pausing and waiting. Get vaccinated."
New Jersey's Department of Health told all vaccination sites to
suspend Johnson & Johnson appointments until further notice.
Gov. Phil Murphy said at a bill signing Tuesday that the state has
administered about 235,000 Johnson & Johnson vaccines with no
reported adverse effects.
A health department spokeswoman said she didn't know how many
appointments had to be rescheduled statewide due to the pause,
since vaccination sites are responsible for their own
Write to Kate King at Kate.King@wsj.com
(END) Dow Jones Newswires
April 13, 2021 15:32 ET (19:32 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.